Raymond J. Hohl, MD, PhD - Penn State Cancer Institute
Raymond J. Hohl, MD, PhD
View My Publications
- Hematology/Oncology
- Clinical Pharmacology
- Clinical and Translational Research
- Hematology
- Medical Oncology
Dr. Hohl began his career at the University of Iowa, College of Medicine in 1991, where he served as assistant professor in the department of internal medicine. He became an assistant professor in the department of pharmacology in 1993 and was promoted to associate professor of both internal medicine and pharmacology in 1997. Dr. Hohl became the director of the division of hematology, oncology and blood and marrow transplantation at the Roy J. and Lucille A. Carver College of Medicine, University of Iowa in 1995. In 1999, he became the associate director for clinical research for the Holden Comprehensive Cancer Center at The University of Iowa. Dr. Hohl was named the director of the fellowship program, division of hematology, oncology and blood and marrow transplantation department of internal medicine at the Roy J. and Lucille A. Carver College of Medicine, University of Iowa in 2000. He was promoted to professor of both internal medicine and pharmacology in 2002 and named associate chair to the department of internal medicine in 2005. At that time he was also named associate director for clinical translational research for the Holden Comprehensive Cancer Center at The University of Iowa. In 2013, Dr. Hohl was named director of the Penn State Cancer Institute, professor of medicine and pharmacology at the Penn State College of Medicine, Penn State University, and holds the university professorship in medicine. Dr. Hohl is a medical oncologist, hematologist and clinical pharmacologist and has broad experience as a clinical and translational researcher.
- Hematology Oncology Education
- International expert in isoprenoid metabolism
- MD/PhD Program
- Physician Scientist Training Program
- Student supervision
- University Professorship in Medicine
- Professor of Medicine and Pharmacology
- Director, Penn State Cancer Institute
- Prostate cancers
- Isoprenoid pathway as it applies to human health and disease, specifically as related to cancers
- Human brain tumors
- Young Investigator Award, American Society of Clinical Oncology in 1992
- Paul E. Carson, Pharmacology Award in 1988
- Outstanding Research Award, GCRC Program Directors' Association in 1996
- Outstanding Research Award in Clinical Pharmacology, Central Society for Clinical Research in 1995
- Laureate Award, American College of Physicians in 2001
- Clinical Pharmacology Faculty Development Award, Pharma Foundation in 1992
- Carver Clinician, Scientist Award in 1991
- Bone Marrow Transplantation
- Leukemia and Lymphoma